Product Information
OXYCODONE HCL (IR) 5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0884 per EA under NDC 64380025901. Its NADAC has been published 104 times since Oct 9, 2024.
FDA first approved this application on Jan 31, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380025901
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OXYCODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077712FDA Approved
1/31/2007
TE Code
AB
On Market Since
9/10/2024
Pharmacological Classes
Price Statistics
The NADAC for OXYCODONE HCL (IR) 5 MG TABLET has been published 104 times since Oct 9, 2024, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0884 per EA |
|---|---|
| All-time high | $0.1060 (Oct 16, 2024) |
| All-time low | $0.0814 (Nov 20, 2024) |
| 52-week high | $0.0944 |
| 52-week low | $0.0865 |
| Median price | $0.0904 |
| Average price | $0.0906 |
| Largest weekly change | -19.0% (Nov 20, 2024) |
| Weeks tracked | 104 |
| Tracking since | Oct 9, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Oxycodone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OXYCODONE HCL (IR) 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYCODONE HCL (IR) 5 MG TABLET, manufactured by Strides Pharma Inc., is $0.0884 per EA (NDC 64380025901), effective Sep 30, 2026.
How has the price of OXYCODONE HCL (IR) 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYCODONE HCL (IR) 5 MG TABLET has declined 16.6%. It has been tracked across 104 weekly CMS publications since Oct 9, 2024.
What are the highest and lowest recorded NADAC prices for OXYCODONE HCL (IR) 5 MG TABLET?
Since Oct 9, 2024, the NADAC for OXYCODONE HCL (IR) 5 MG TABLET has ranged from a low of $0.0814 (Nov 20, 2024) to a high of $0.1060 (Oct 16, 2024), with a median of $0.0904 per EA.
Are there cheaper alternatives to OXYCODONE HCL (IR) 5 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYCODONE HCL (IR) 5 MG TABLET, is $0.0789 per EA — about 11% below OXYCODONE HCL (IR) 5 MG TABLET.
Who manufactures OXYCODONE HCL (IR) 5 MG TABLET?
OXYCODONE HCL (IR) 5 MG TABLET (NDC 64380025901) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.